Low glucose-1, 6-bisphosphate and high fructose-2, 6-bisphosphate concentrations in muscles of patients with glycogenosis types VII and V.
The level of glucose-1, 6-bisphosphate, a potent allosteric activator of phosphofructokinase, was markedly decreased in muscles of patients with glycogenosis type VII (muscle phosphofructokinase deficiency) and type V (muscle phosphorylase deficiency). Glucose-1-phosphate kinase activity in muscle was virtually absent in a patient with glycogenosis type VII, whereas it was normal in a patient with type V glycogenosis. Glucose-1-phosphate level was increased in type VII glycogenosis, whereas it was decreased in type V glycogenosis. Another activator of phosphofructokinase, fructose-2, 6-bisphosphate was increased in muscles of patients with both types of glycogenosis although it was much higher in type VII than in type V. This finding may be partly related to the difference of fructose-6-phosphate concentrations. The results suggest that phosphofructokinase would contribute to the major glucose-1-phosphate kinase activity in normal human muscle and would also form a kind of self-activating system.
Yamada
Y
Y
Second Department of Internal Medicine, Osaka University Medical School, Japan.
Kono
N
N
Nakajima
H
H
Shimizu
T
T
Kiyokawa
H
H
Kawachi
M
M
Ono
A
A
Nishimura
T
T
Kuwajima
M
M
Tarui
S
S
D005635:Fructosediphosphates / Q000032:analysis*; D019298:Glucose-6-Phosphate / Q000031:analogs & derivatives*; D005958:Glucosephosphates / Q000032:analysis*; D006003:Glycogen / Q000032:analysis; D006012:Glycogen Storage Disease Type V / Q000378:metabolism*; D006014:Glycogen Storage Disease Type VII / Q000378:metabolism*; D006019:Glycolysis; D006801:Humans; D009132:Muscles / Q000737:chemistry* / Q000378:metabolism; D012016:Reference Values
D005635:Fructosediphosphates; D005958:Glucosephosphates; D019298:Glucose-6-Phosphate; C027652:fructose 2,6-diphosphate; D006003:Glycogen; C016473:glucose-1,6-bisphosphate